Join the MetroWest Life Sciences Network for a Fall Networking Event on Wednesday, September 28th from 4:30 PM - 7:30 PM!

About this event

Mix and mingle with life science professionals from MetroWest and beyond in the biotech industry. There will be free appetizers and drinks during this event.

MetroWest Life Science Network is raising funds for the MetroWest Life Science Network: Scholarship Fund. This scholarship is to assist students in eliminating financial barriers that they may face during their education. If unable to attend, please consider donating by clicking register. Even small donations add up!

We look forward to seeing you there!

RAINDATE: Thursday, September 29th, 2022

*Please note that this event will require proof of vaccination to ensure the safety of all.

In-person Networking is Back! The Mansfield Bio-Incubator and Halloran Consulting invite you to a seminar and a networking event

 Wednesday, May 4, 2022

Know What You’re Getting Into: Breaking Down the Clinical Development Process

11:00 am-12:30 pm

at the Mansfield Bio-Incubator 241 Francis Avenue Mansfield, MA 02048

Directions: http://bit.ly/2y4EZe9

Description: 

The journey from discovery, through clinical trials and to commercialization is a long, challenging, and complex venture that ends in failure more often than not. Life science entrepreneurs can set themselves up for success by developing an understanding of the numerous regulatory and clinical hurdles that must be overcome.

Please join Halloran Consulting Group’s Matthew Cardinal, Vice President of Strategy & Program Leadership, for a presentation entitled “Know What You’re Getting Into: Breaking Down the Clinical Development Process”.

This presentation will teach the basics of the entire drug development process, from bench to bedside. A certain portion of the presentation is intended to be interactive, so all attendees are asked to come ready to share their stories, questions, and concerns.

Who should attend: Life science entrepreneurs.

Agenda:

11:00-11:05 PM: Introduction by Alex Margulis, Chief Operating Officer, Mansfield Bio-Incubator

11:05 PM-12:00 PM: Presentation and Q&A

12:00 PM-12:30 PM: Networking

About Halloran Consulting

Halloran Consulting Group is a life science consulting firm that provides strategic regulatory, quality, clinical, and organizational support to industry leaders and startup visionaries in the pharmaceutical, biotechnology, and medical device sectors. Our consultants are subject matter experts who deliver a tailored approach to each engagement, successfully propelling our clients to their next inflection point. We connect clients with our trusted industry partners to drive operational excellence and innovation throughout their organizations. Our aim is to support our clients, and the patients they serve.

Learn more at: https://www.hallorancg.com/

Additional Information

Please note: Mansfield Bio-Incubator is taking all appropriate precautions while also closely monitoring the latest public health guidance on COVID-19.

NCI SBIR workshop on the grant opportunities in biotech, pharma, medical devices, and other healthcare and life science areas.

About this Event

Mansfield Bio-Incubator is pleased to host The National Cancer Institute’s Small Business Innovation Research (NCI SBIR) Development Center. The center provides funding, networking, and mentoring assistance to small businesses with innovative cancer technology projects. On March 16, 2022, NCI SBIR Program staff, Xing-Jian Lou and Nancy Kamei, will be presenting funding opportunities and other commercialization resources for small businesses in biotech, pharma, medical devices, and other life science and healthcare areas. During the presentation, the topics covered will include:

• New and existing funding opportunities

• Investor and training programs such as the I-Corps at NIH entrepreneurship program

• Application tips and suggestions

Following the presentation, companies will have a chance to meet one-on-one with Xing-Jian Lou and Nancy Kamei to discuss their cancer technology project and funding eligibility. If you would like to be considered for a one-on-one meeting, please contact Alex Margulis by March 16, 2022 at alex.margulis@bioinc.org with a one-page summary of your company and technology.

Who should attend: Life science entrepreneurs/professionals who are looking for non-dilutive sources of money such as SBIR grants.

Agenda:

2:00 – 2:05 Housekeeping

2:05 – 2:10 Introduction to Mansfield Bio-Incubator

2:10 – 2:45 NCI SBIR Presentation

2:45 – 3:00 Audience Q&A

3:00 - 4:00 One-on-one Meetings

NCI SBIR workshop on the grant opportunities in biotech, pharma, medical devices, and other healthcare and life science areas.

About this Event

Mansfield Bio-Incubator is pleased to host The National Cancer Institute’s Small Business Innovation Research (NCI SBIR) Development Center. The center provides funding, networking, and mentoring assistance to small businesses with innovative cancer technology projects. On September 15, 2021, NCI SBIR Program staff, Xing-Jian Lou and Nancy Kamei, will be presenting funding opportunities and other commercialization resources for small businesses in biotech, pharma, medical devices, and other life science and healthcare areas. During the presentation, the topics covered will include:

• New and existing funding opportunities

• Investor and training programs such as the I-Corps at NIH entrepreneurship program

• Application tips and suggestions

Following the presentation, companies will have a chance to meet one-on-one with Xing-Jian Lou and Nancy Kamei to discuss their cancer technology project and funding eligibility. If you would like to be considered for a one-on-one meeting, please contact Alex Margulis by September 13 at alex.margulis@bioinc.org with a one-page summary of your company and technology.

Who should attend: Life science entrepreneurs/professionals who are looking for non-dilutive sources of money such as SBIR grants.

Agenda:

2:00 – 2:05 Housekeeping

2:05 – 2:10 Introduction to Mansfield Bio-Incubator

2:10 – 2:45 NCI SBIR Presentation

2:45 – 3:00 Audience Q&A

3:00 - 4:00 One-on-one Meetings

Alira Health and Mansfield Bio-Incubator present, a U.S. Regulatory Update with Alira Health’s Mary McNamara-Cullinane, Senior VP Regulatory

About this Event

Join Alira Health’s Senior Vice President, Regulatory Affairs, Mary McNamara-Cullinane for a timely, interactive event, where Mary will give an update on the FDA, including a walkthrough of the EUA process, and best practices for submission development based on the latest FDA guidance.

Who should attend: Entrepreneurs in biotech, pharmaceuticals, medical devices, and other healthcare-related fields planning to approach FDA within the next year. Investors in these fields looking for guidance.

The presentation will be followed by a question-and-answer session.

About Alira Health

At Alira Health, our mission is to enable healthcare transformation. We support life sciences organizations with a lifecycle of services to uncover opportunities, accelerate innovation, and improve outcomes for patients around the world.

And we don’t just advise, we innovate right alongside our clients through Alira Health Ventures: a state-of-the-art incubator space where new products are researched, developed, and taken to market.

Our team helps simplify the complicated journey that is the healthcare and life sciences product and corporate lifecycles — so your team can innovate, grow, and achieve success at every turn.

To learn more, visit www.alirahealth.com

About Mansfield Bio-Incubator

Mansfield Bio-Incubator is a non-profit biotech, pharma, life science, and medical device business incubator facility. Our mission is to facilitate and assist the creation, growth, and success of the next generation of biotech, pharma, life science, and medical device companies. We were created to nurture entrepreneurial and economic development in the community. We aim to do this by maintaining affordable lab and office space and making cutting-edge technology, services, training, mentoring, and a network of professional advisors available to small biotechnology companies and healthcare-related start-ups. Furthermore, our member companies are eligible for the newly-established MLSC Seed Fund Program.

To learn more, visit https://www.masslifesciences.com/programs/seedfund/

Mansfield Bio-Incubator is a proud recipient of Massachusetts Life Science Center's Open Capital Program Grant and is planning to expand by 15,000 square feet by the end of 2021. The newly-built space will include private laboratory suites and more shared lab space and state-of-the art equipment.

To learn more, visit https://www.bioinc.org/upcoming-expansion

Interested in becoming a member, sponsor, partner , or mentor?

Visit https://www.bioinc.org/

NCI SBIR workshop on the grant opportunities in biotech, pharma, medical devices, and other healthcare and life science areas.

About this Event

Mansfield Bio-Incubator is pleased to host The National Cancer Institute’s Small Business Innovation Research (NCI SBIR) Development Center. The center provides funding, networking, and mentoring assistance to small businesses with innovative cancer technology projects. On February 24 2021, NCI SBIR Program staff, Xing-Jian Lou and Nancy Kamei, will be presenting funding opportunities and other commercialization resources for small businesses in biotech, pharma, medical devices, and other life science and healthcare areas. During the presentation, the topics covered will include:

• New and existing funding opportunities

• Investor and training programs such as the I-Corps at NIH entrepreneurship program

• Application tips and suggestions

Following the presentation, companies will have a chance to meet one-on-one with Xing-Jian Lou and Nancy Kamei to discuss their cancer technology project and funding eligibility. If you would like to be considered for a one-on-one meeting, please contact Alex Margulis by February 23 at alex.margulis@bioinc.org with a one-page summary of your company and technology.

Who should attend: Life science entrepreneurs/professionals who are looking for non-dilutive sources of money such as SBIR grants.

Agenda:

2:00 – 2:05 Housekeeping

2:05 – 2:10 Introduction to Mansfield Bio-Incubator

2:10 – 2:45 NCI SBIR Presentation

2:45 – 3:00 Audience Q&A

3:00 - 4:00 One-on-one Meetings

The Mansfield Bio-Incubator and Allevi invite you to an online event

Tuesday, August 4, 2020  

Bring your work to life with Allevi 3D bioprinters: What will you build?

11:00 am- 12 noon

 ONLINE EVENT

Description: 

Allevi creates tools and solutions to design, engineer and build with life. Our 3D bioprinters, Bioprint software and bioinks are used by leading researchers around the world to find solutions to humanity’s most difficult problems. 

We created our desktop 3D bioprinters to be the most versatile, powerful and easy-to-use bioprinters on the market. Our syringe-based bioprinters enable users to experiment with any biomaterial, work with any cell line and print in any geometry. Our bioprinters and Bioprint Software empower novice and expert 3D bioprinting users alike to quickly and easily achieve their goals.

We believe everyone has the potential to change the course of medicine for the better. What will you build?

Who should attend: Life science entrepreneurs and anyone else interested in 3D Bioprinting.

 
Come see the printer in action!

Description:

In recent years, crowdfunding emerged as an alternative source of startup funds generating almost $10B of seed funds. Host, Mark Norige, will review the basics of crowdfunding and moderate a discussion with experts on similarities of alternative and traditional capital investment approaches. Attend to learn how popular crowdfunding options work and if any are right for your business. Who should attend: early-stage entrepreneurs, particularly in life sciences, biotech, biopharma, medical devices, and healthcare.

Host Mark Norige is the Principal and CEO of the Board Forum, a successful CEO peer advisory firm and Chief Executive Manager of CHP LLC, an early stage medicinal products company. He also advises early-stage businesses and is an Advisory Board member of Mansfield Bio-Incubator. Mark brings 30 plus years of business leadership experience helping small to mid-size companies grow revenue and profits by conducting analysis of their business and guides them to develop strategies and execution plans to achieve their desired results. Prior to the Board Forum, Mark worked in a variety of leadership roles for both early-stage and Fortune 300 global companies including; Texas Instruments, Waters, Millipore, and Harvard Bioscience along with several early-stage investor backed firms. He is an adjunct professor in the graduate program in innovation and entrepreneurship at Brown University and earned his B.S. from UMASS and a Babson College MBA.

Guest Lily Macomber’s career spans various startups including non-profits and educational institutions such as MIT’s all in support of entrepreneurs and The Startup Network. She holds a BA from Providence College and is currently working on her MBA from Babson College. She currently responsible for business development at Netcapital, a fintech startup based in Boston. lily.macomber@netcapital.com

Guest Ilonna J. Rimm, MD, PhD, CFA advises Life Science CEO’s who are raising a Series A round of capital. She was instrumental in raising a $17M Series A financing for Immuneering Corporation in December of 2019. Dr. Rimm’s previous financing and investment experience includes: Trillium Asset Management, Lazard Capital Markets, Leerink Swann and Company, and Oxford Bioscience Partners. She has pharmaceutical company experience from Wyeth Pharmaceuticals. She is a Harvard-trained physician-scientist, with extensive experience in Oncology (Pediatric Hematology/Oncology) and Immunology. She worked both in leadership and in hands-on clinical and laboratory roles associated with the Dana-Farber Cancer Institute, Children’s Hospital and Harvard Medical School for two decades. ijrimm@expertise4innovation.com

Description:

As a highly educated science expert, you’re developing the next best medical breakthrough. Yet, great sicence is necessary but not sufficient to succeed in the long run. Mastering key business aspects is also critical. These include: raising money, managing that money, developing a commercialization plan, and thinking about global markets. Conversely, ignoring these essential business development tenets would likely set you up for failure.

Come hear a panel of experts speak on critical tips to master the business side of the science!

Learn about:

• Critical components of an effective strategic plan

• Due diligence to perform to align your science and business

• Steps to improve your odds of success

• How to raise the right money at the right time

• Timing to consider global markets

• The biggest mistakes and how to avoid them

Who should attend: Early-stage entrepreneurs, investors, and business development professionals in life sciences.

THIS IS A 5 WEEK SERIES

Webinar #1 – 1 hour

Navigating the alphabet soup of regulations. You will learn all areas of your business where you will need to make changes and considerations for new rules, new equipment, new processes and adapt the factors you consider in decision making.

Description: 

The panel will discuss the funding trends in the Medtech industry, and the best Corporate and IP practices for early stage Medtech companies to secure funding. The topics will include:

• Funding trends for early stage Medtech companies

• 2019 v. 2018, 4th quarter 2019, 2020 outlook, etc.

• Differences for various medical technologies (biotech, devices, healthcare IT, services, etc.) and stages (early vs. late)

• 2019 Exits – M&A and IPO trends

• Best IP and Corporate practices

Who should attend: Life science entrepreneurs, investors, and associated service providers.

Speakers: 

Roman Fayerberg-Greenberg Traurig, Shareholder & Patent Attorney
Emily Ladd-Kravitz-Greenberg Traurig, Shareholder and Corporate Attorney
TBA

About Greenberg Traurig, LLP: Greenberg Traurig, LLP (GT) has approximately 2100 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100.

Web: https:// www.gtlaw.com

The Mansfield Bio-Incubator and Alira Health invite you to a seminar and a networking event 

Wednesday, February 26, 2020   

Investor Deck: Maximizing Your Chances of Success.

11:30 am- 1:30 pm

at the Mansfield Bio-Incubator
241 Francis Avenue
Mansfield, MA 02048

Directions: http://bit.ly/2y4EZe9

Description:

An Investor Deck is a critical tool for every life sciences organization to showcase their value to prospective investors, and in this interactive session, we invite an expert panel from Alira Health to talk through critical deck components and discuss how to engage, invest, and maximize value and different inflection points of your growth. The panel will include insights from a regulatory, clinical, strategic, and investor perspective, and will provide you with information and ideas for maximizing value and every stage of your development.

Is your business missing out on this additional source of cash flow?

Small businesses and startups comprise the vast majority of companies in the US, consistently stimulating the economy through growth and innovation.  However, many of these companies are not aware of all the financial incentives available to them, including the Research and Development (R&D) Tax Credit.

Leyton is pleased to host this webinar in partnership with the ACTION Innovation Network to share how companies in the network can increase their cash flow through the R&D Tax Credit.

This webinar will cover:

• How can the R&D Credit provide additional cash flow?

  • An Introduction to the R&D Tax Credit

  • An Introduction to the Payroll Tax Credit for startups

    • Is my business eligible? What is a Qualified Small Business?

• Who is eligible to claim?

  • 4 Part Test

  • Industries

• How do I claim this credit for my company’s R&D?

  • Best practices

• Leyton with contact information + Q&A

This webinar will be presented by Leyton, a global R&D Tax Credit consulting firm.  Their team of highly experienced scientists, engineers, tax consultants and tax attorneys implement strategies to claim the R&D Tax Credit, ensuring maximum eligible financial return without impacting a company’s core business.

JP Morgan Conference Review and Winter Social with Lightning Pitches

Make new connections and hear the latest industry updates at our Tenth Anniversary and 6th Annual Winter Networking Social with Lightning Pitches!

J.P. Morgan Conference Review: We are excited to announce our keynote speaker, Bruce Robertson, Managing Director H.I.G. Capital. Just returning from the 2020 J.P. Morgan Healthcare Conference, Bruce will provide our members with a recap from one of the most influential healthcare investment conferences. Find out what the experts are saying about the overall market, future of drug pricing, regulatory environment and capital markets.

Lightning Pitches: During the lighting pitch segment, we will learn more about members whose companies provide valuable services that enable the growth of our healthtech ecosystem. Each pitching company will have 1 minute to impress us with their value proposition. There will also be plenty of opportunity to network with the companies and fellow members.

Are you thinking about and doing the right things to make your business the most successful it can be?

About this Event

A complimentary workshop entitled “Think, act and grow rich. Entrepreneur hacks” is set for Thursday, January 16, 2020 from 6:00-7:30PM at the Mansfield Bio Incubator, 241 Francis Avenue, Mansfield, MA.

The workshop will explore four strategies for thinking critically about your business to help it to grow and thrive.

• What is your next best move? Where is your business on the business life cycle and what are the implications for its future success?

• Are you focused? How do you keep your focus on your vision, goals, projects and actions?

• Are your employees your biggest asset? Do your employees embrace change? If not, what is causing their reluctance and how can you change it?

• What makes your business different? Knowing what makes you different and finding ways to exploit the differences can dramatically improve performance.

The workshop will be led by Dominic Grew and Lisa Levesque who are certified business coaches and trainers with FocalPoint International Coaching & training.

Grew has more than 25 years of proven business development experience, building, growing and leading change, primarily in financial service companies. Dominic earned a Masters in Management from Cambridge College. Dominic is originally from Belfast , Northern Ireland, but today calls Sharon, MA home, where he lives with his wife and three children.

Levesque is a leader in business productivity and has helped Fortune 500 companies reduce costs while increasing revenue and gaining market share. Lisa is a graduate of Boston College, with a degree in Accounting and earned an MBA from Babson College. She resides in Foxboro, MA with her husband, two daughters and two dogs.

For more information, please contact Steven V. Dubin at SDubin@MyPinnacleNetwork.com or 781-582-1061.

Description: 

A clear-eyed understanding of the reimbursement landscape is essential to any life science startup’s ability to effectively pursue financing, product development and commercialization. A fully integrated clinical, regulatory and reimbursement plan, responsive to the obstacles and opportunities presented by a rapidly evolving healthcare reimbursement system, can optimize resource utilization and time to revenue and can dramatically change the odds of success.

Join Ed Berger, Principal and Founder of reimbursement consultancy Larchmont Strategic Advisors, for an exploration of the fundamental elements of the reimbursement landscape and practical guidance on how and when to address reimbursement strategy issues for your diagnostic, therapeutic or medtech innovation.

If you want to become a successful life science entrepreneur, it is essential to learn early on how the key stakeholders are going to pay for your product, no matter how great it is.

Who should attend: Early-stage entrepreneurs in life sciences.

Description: 

Mansfield Bio-Incubator invites you to attend its second annual Open House on November 5, 2019 in Mansfield, Massachusetts. Come join in the fun and see how innovative startup companies are transforming the world with game-changing inventions in life science!

Over the past year,  we have added several new exciting startups while our resident companies have been growing and made progress in their research. We are now gearing to expand beyond our 10,000 sqft space and are catalyzing the transformation of the entire 63-acre former glass bottling factory into a 21st century Life Science R&D and manufacturing campus.  This transformation is all due to the cutting edge science and product development going on in the proof of concept laboratories in the incubator.  We have nucleated the life science ecosystem South of Boston and the success is due to you!

Come see for yourself that the biotechnology super-cluster extends along the South of Boston innovation corridor right here to Mansfield, Massachusetts. Join in the celebration and envision a future for yourself and your company alongside these pioneers.

Description: 

As of July 2019, the US has approved reimbursement codes for point-of-care 3D printing devices. The hospital of the future will incorporate 3D printing to reduce costs and boost healthcare quality with personalized treatments.

This seminar presents the unique benefits of 3D bioprinting as a powerful tool for biomedical research as well as a translatable technology into the clinic. By combining automation and computer-aided design with the knowledge of structural organization and material composition of native tissues, bioprinting offers added values of precision, experimental repeatability, and architectural complexity to traditional tissue engineering that helps to create tissues with higher cell viability and functionality.

This seminar also introduces ROKIT’s work in the development of medical 3D bioprinting kits that combine the hardware, software, biomaterials, and protocols, which can be readily adopted by hospitals to treat patients and directly translate 3D printing combined with stem cell therapy into improved clinical outcomes.

Finally, the seminar reinforces the field of 3D bioprinting in the 4th industrial revolution as a movement aligned with global megatrends in healthcare toward personalized medicine, computer-aided production of biological processes, and autologous cell therapy.

Following the discussion, watch the 3D printer in action!

Who should attend: Life science entrepreneurs, health care providers and anyone else interested in learning more about 3D printing, specifically for biomedical applications

Description: 

You know starting a new business is not easy. It requires many skills and if you’re like most leaders, you want to improve these skills while identifying and addressing your blind spots. 

Imagine what you could gain from the insights and advice of a team of highly talented people, from diverse industries, who are willing to share their knowledge and experience with you in your mission to create a sustainable, profitable business.

Here’s how: 

The Board Forum® and the Mansfield BIO Incubator, in collaboration, announce a new format advisory roundtable designed expressly for early-stage businesses. 

Modeled after the successful peer to peer advisory, the Board Forum, this new format, called The Board Forum - GENESIS aims to help CEO's, business founders, and leaders of early stage and startup businesses, to develop their skills through peer advising and by discovering new solutions to their pressing business challenges such as; sustaining growth, developing teams, funding, adjusting strategy, planning and managing change. The Board Forum - GENESIS is focused exclusively on the unique challenges faced by early-stage businesses and membership is limited to only them.

Ideal candidates are leaders of an existing early stage, startup business who; 

• are looking to grow and scale it to the next level;

• have a significant business problem or problems that have them challenged;

• want to improve and develop their leadership and teams and;

• seek ways to invigorate their thinking to find faster routes to reach their goals.

Facilitated by Mark Norige, Principal and CEO of the Board Forum, a successful CEO peer advisory firm, and Chief Executive Manager of CHP LLC, an early stage medicinal products company.

Description: 

You know starting a new business is not easy. It requires many skills and if you’re like most leaders, you want to improve these skills while identifying and addressing your blind spots. 

Imagine what you could gain from the insights and advice of a team of highly talented people, from diverse industries, who are willing to share their knowledge and experience with you in your mission to create a sustainable, profitable business.

Here’s how: 

The Board Forum® and the Mansfield BIO Incubator, in collaboration, announce a new format advisory roundtable designed expressly for early-stage businesses. 

Modeled after the successful peer to peer advisory, the Board Forum, this new format, called The Board Forum - GENESIS aims to help CEO's, business founders, and leaders of early stage and startup businesses, to develop their skills through peer advising and by discovering new solutions to their pressing business challenges such as; sustaining growth, developing teams, funding, adjusting strategy, planning and managing change. The Board Forum - GENESIS is focused exclusively on the unique challenges faced by early-stage businesses and membership is limited to only them.

Ideal candidates are leaders of an existing early stage, startup business who; 

• are looking to grow and scale it to the next level;

• have a significant business problem or problems that have them challenged;

• want to improve and develop their leadership and teams and;

• seek ways to invigorate their thinking to find faster routes to reach their goals.

Facilitated by Mark Norige, Principal and CEO of the Board Forum, a successful CEO peer advisory firm, and Chief Executive Manager of CHP LLC, an early stage medicinal products company.

Learn about funding opportunities with the NIH/NCI. Optional one-on-ones 12:30-2:30pm (details below).

About this Event

The National Cancer Institute’s Small Business Innovation Research (NCI SBIR) Development Center provides funding, networking, and mentoring assistance to entrepreneurs with innovative cancer technology projects. On Tuesday, September 10, NCI SBIR Program Director Ashim Subedee, PhD will be presenting funding opportunities and other commercialization resources to take your technology from lab to market. During the presentation, Dr. Subedee will cover topics including:

o SBIR/STTR 101

o New and existing funding opportunities

o NIH-funding resources for entrepreneurs

o Practical strategies and tips on how to successfully submit competitive research proposals

Dr. Subedee will be available for a limited number of one-on-one meetings to discuss your projects/application from 12:30 – 2:30 pm. If you would like to sign up for a 15-20 minute meeting, please register first, and then send your name, company name, and a one-page summary of your technology to ncisbir@mail.nih.gov. The meeting slots will be filled on a rolling basis and you will receive notification regarding time of your meeting.

Description:

Join us for the workshop with George Moker, the Director of Government Contracting atAmbrosi Donahue Congdon, CPA. With over 10 years of experience with SBIR/STTR Accounting, George will cover topics such as labor distribution, indirect rate management, payroll, and much more. Don't miss this opportunity to learn how to get the most out of our award and set yourself up for success.